Japan Medical Dynamic Stock Current Valuation
JMD Stock | EUR 3.66 0.06 1.61% |
Valuation analysis of Japan Medical Dynamic helps investors to measure Japan Medical's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Undervalued
Today
Please note that Japan Medical's price fluctuation is somewhat reliable at this time. Calculation of the real value of Japan Medical Dynamic is based on 3 months time horizon. Increasing Japan Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Japan stock is determined by what a typical buyer is willing to pay for full or partial control of Japan Medical Dynamic. Since Japan Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Japan Stock. However, Japan Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 3.66 | Real 3.88 | Hype 3.66 | Naive 3.76 |
The real value of Japan Stock, also known as its intrinsic value, is the underlying worth of Japan Medical Dynamic Company, which is reflected in its stock price. It is based on Japan Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Japan Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Japan Medical Dynamic helps investors to forecast how Japan stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Japan Medical more accurately as focusing exclusively on Japan Medical's fundamentals will not take into account other important factors: Japan Medical Dynamic Company Current Valuation Analysis
Japan Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Japan Medical Current Valuation | 168.86 M |
Most of Japan Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Japan Medical Dynamic is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition |
In accordance with the recently published financial statements, Japan Medical Dynamic has a Current Valuation of 168.86 M. This is 98.82% lower than that of the Healthcare sector and 98.64% lower than that of the Medical Devices industry. The current valuation for all Germany stocks is 98.98% higher than that of the company.
Japan Medical Dynamic is considered the number one company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Medical Devices industry is currently estimated at about 1.98 Billion. Japan Medical holds roughly 168.86 Million in current valuation claiming about 9% of all equities under Medical Devices industry.Japan Fundamentals
Return On Equity | 0.0758 | |||
Return On Asset | 0.0496 | |||
Profit Margin | 0.08 % | |||
Operating Margin | 0.10 % | |||
Current Valuation | 168.86 M | |||
Shares Outstanding | 26.38 M | |||
Shares Owned By Insiders | 43.07 % | |||
Shares Owned By Institutions | 22.93 % | |||
Price To Earning | 21.58 X | |||
Price To Book | 1.06 X | |||
Price To Sales | 0.01 X | |||
Revenue | 19.19 B | |||
Gross Profit | 12.99 B | |||
EBITDA | 4.2 B | |||
Net Income | 2.13 B | |||
Cash And Equivalents | 21.19 M | |||
Cash Per Share | 0.80 X | |||
Total Debt | 1.25 B | |||
Debt To Equity | 29.70 % | |||
Current Ratio | 2.88 X | |||
Book Value Per Share | 871.68 X | |||
Cash Flow From Operations | 3.11 B | |||
Earnings Per Share | 0.43 X | |||
Number Of Employees | 474 | |||
Beta | 0.29 | |||
Market Capitalization | 187.2 M | |||
Total Asset | 27.34 B | |||
Annual Yield | 0.03 % | |||
Five Year Return | 0.87 % | |||
Net Asset | 27.34 B | |||
Last Dividend Paid | 12.0 |
About Japan Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Japan Medical Dynamic's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Japan Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Japan Medical Dynamic based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Japan Stock
Japan Medical financial ratios help investors to determine whether Japan Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Japan with respect to the benefits of owning Japan Medical security.